Ndufa4l2 drives the pathological activation of Müller cells in ischemic retinopathy via the PI3K/AKT signaling pathway.

Liu P, Lou L, Zhang Y, Yan X, Zhang Y, Wang Y, Sun J.

Open source

DOI
10.1016/j.prp.2026.156567
Published
2026-05-30
Container
Pathol Res Pract
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.prp.2026.156567,
  title = {Ndufa4l2 drives the pathological activation of Müller cells in ischemic retinopathy via the PI3K/AKT signaling pathway.},
  author = {Liu P and  Lou L and  Zhang Y and  Yan X and  Zhang Y and  Wang Y and  Sun J.},
  year = {2026},
  journal = {Pathol Res Pract},
  doi = {10.1016/j.prp.2026.156567},
  url = {https://doi.org/10.1016/j.prp.2026.156567}
}

RIS

TY  - JOUR
TI  - Ndufa4l2 drives the pathological activation of Müller cells in ischemic retinopathy via the PI3K/AKT signaling pathway.
AU  - Liu P
AU  -  Lou L
AU  -  Zhang Y
AU  -  Yan X
AU  -  Zhang Y
AU  -  Wang Y
AU  -  Sun J.
PY  - 2026
JO  - Pathol Res Pract
DO  - 10.1016/j.prp.2026.156567
UR  - https://doi.org/10.1016/j.prp.2026.156567
ER  - 

APA

P, L., L, L., Y, Z., X, Y., Y, Z., Y, W., & J., S. (2026). Ndufa4l2 drives the pathological activation of Müller cells in ischemic retinopathy via the PI3K/AKT signaling pathway.. Pathol Res Pract. https://doi.org/10.1016/j.prp.2026.156567

Source records